Table 3. Details of endocrine therapies prior to study enrolment.
| n (%, n=24) | First hormonal regimen | Second hormonal regimen | Third hormonal regimen | Fourth hormonal regimen |
|---|---|---|---|---|
| 1 (4.2) |
None |
None |
None |
None |
| 8 (33.3) |
AI |
None |
None |
None |
| 3 (12.5) |
AI |
AI |
None |
None |
| 1 (4.2) |
AI |
Othera |
None |
None |
| 1 (4.2) |
Tamoxifen |
AI |
None |
None |
| 2 (8.3) |
Tamoxifen |
AI |
Unknown |
None |
| 1 (4.2) | Tamoxifen | Megestrol | Unknown | Unknown |
Abbreviation: AI=aromatase inhibitor.
a
Other: not specified, but not tamoxifen, AI, ovarian suppression/ablation or megestrol.